Final Agenda for CHI’s Seventh Annual NGx: Applying Next-Generation Sequencing Conference

A Three Day Event Focusing on the Challenges in Next-Generation Sequencing
 
May 14, 2012 - PRLog -- NEEDHAM, MASS. – May 14, 2012 – Cambridge Healthtech Institute is pleased to announce the final agenda for the seventh annual NGx: Applying Next-Generation Sequencing. Next-generation sequencing (NGS) has expanded our fundamental understanding of genomics, mutation, gene function and regulation, by delivering fast, precise, and large volumes of data. As the cost of sequencing declines, use in academic, biotech, medical, pharmaceutical, and ag-bio labs expands, paving the way for the creation of innovative new areas for bioresearch. Still, the question remains of how best to balance cost, quantity and quality when choosing a sequencing platform or service. This three day event investigates the expanding applications of NGS. Learn from experienced researchers from large sequencing centers, core laboratories, and specialized groups as they share their practical real-world experiences and solutions. Join us August 13-15, 2012 at the West Providence Hotel in Providence, RI. For more information, please visit http://www.healthtech.com/sqe.

Speakers Include:  (partial listing)

- Nancy J. Kelley, J.D., M.P.P., Founding Executive Director, New York Genome Center

- George Weinstock, Ph.D., Associate Director, The Genome Institute, Washington University

- Sheila Fisher, Assistant Director, Technology Development, Genome Sequencing Platform, The Broad Institute

- W. Richard McCombie, Ph.D., Resource Head, Cancer Center; Professor, Cold Spring Harbor Laboratory

- Shrikant Mane, Ph.D., Senior Research Scientist, Genetics; Senior Deputy Director, MBB Keck Biotech Services; Director,   Microarray Resource, Yale University

- Vanessa M. Hayes, Ph.D., Professor, Genomic Medicine, J. Craig Venter Institute

- Suganthi Balasubramanian, Ph.D., Associate Research Scientist, Molecular Biophysics and Biochemistry, Yale University

- Sijia Lu, Research Scientist in Xie Lab, Department of Chemistry and Chemical Biology, Harvard University

- Marek Malecki, M.D., Ph.D., Associate Professor of Genetics, Genomics, and Gene Therapy, Western University of Health Sciences

- Anthony Shuber, Ph.D., CTO, Applied Science, Predictive Biosciences

- Dan Robinson, Ph.D., Postdoctoral Fellow, Michigan Center for Translational Pathology

- Jason Laramie, Ph.D., Scientific Applications Director, Collaborations, Complete Genomics, Inc.

- Suzy Strickler, Ph.D., Postdoctoral Researcher, Boyce Thompson Institute for Plant Research, Cornell University

- Vance Lemmon, Ph.D., Walter G. Ross Distinguished Chair in Developmental Neuroscience; Professor, Neurological Surgery,   The Miami Project to Cure Paralysis, Center for Computational Sciences, University of Miami Miller School of Medicine

- Marija Drndic, Ph.D., Department of Physics and Astronomy, University of Pennsylvania

- Kenneth Shepard, Ph.D., Associate Professor, Electrical Engineering and Biomedical Engineering, Columbia University

- Stefan Roever, CEO & Founder, Genia Technologies

- Ira M. Hall, Ph.D., Assistant Professor, Department of Biochemistry and Molecular Genetics; Center for Public Health Genomics,   University of Virginia

- Ryan E. Mills, Ph.D., Assistant Professor, Department of Computational Medicine and Bioinformatics; Department of Human  Genetics, University of Michigan Medical School

- Hugues Aschard, Ph.D., Research Fellow, Department of Epidemiology, School of Public Health, Harvard University  

To view the full agenda, please visit http://www.healthtech.com/sqe

Register by May 25, 2012 and save up to $350!

About Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business. www.chicorporate.com

For more information:
Tracey Fielding
Cambridge Healthtech Institute
(781) 972-5429
tfielding@healthtech.com
End
Source: » Follow
Email:***@healthtech.com
Posted By:***@healthtech.com Email Verified
Zip:02494
Tags:Sequencing, Genome, Epigentics
Industry:Science, Research, Health
Location:Needham - Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Cambridge Healthtech Institute PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share